Endogenous risk factors for childhood leukemia in relation to the IGF system (Greece)

Cancer Causes and Control

Volumn 11, Issue 8, 2000, Pages 765-771

  Petridou, Eleni ^a,b   Skalkidou, Alkistis ^a   Dessypris, Nick ^a   Moustaki, Maria ^a   Mantzoros, Christos ^c   Spanos, Evangelos ^d   Trichopoulos, Dimitrios ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d International Diagnostic Centre   (Greece)

Author keywords

Birth weight; Childhood leukemia; Gender; IGF; Insulin like growth factor

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENT; ANEMIA; ARTICLE; BIRTH WEIGHT; CANCER RISK; CHILD; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; GREECE; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR;

CHILD; CHILD, PRESCHOOL; FEMALE; GREECE; HUMANS; INFANT; INSULIN-LIKE GROWTH FACTOR I; LEUKEMIA; MALE; RISK FACTORS;

EID: 0033791263     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008988819494     Document Type: Article

References (34)

1. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia
2. Circulating insulin-like growth factor-I and prostate cancer risks: A prospective study
3. Insulin-like growth factor 1 and prostate cancer risk: A population-based, case-control study
4. Plasma insulin-like growth factor-I (IGF-I) concentrations in human breast cancer
5. Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer
6. Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast
7. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
8. Expression of insulin-like growth factor-2 can predict the prognosis of human colorectal cancer patients: Correlation with tumor progression, proliferative activity and survival
9. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
10. IGF-I and IGF-II in relation to colorectal cancer
11. Plasma levels of insulin-like growth factor-I and lung cancer risk: A case-control analysis
12. Growth hormone/insulin-like growth factor-I axis in aging: A summary of a National Institutes of Aging-sponsored symposium
13. Insulin-like growth factor-I and binding protein-3 in relation to childhood leukaemia
14. Does growth hormone increase the risk of malignancies?
15. Birth characteristics of children dying of malignant neoplasms
16. Birth weight as a risk factor for childhood acute lymphoblastic leukaemia
17. Maternal and perinatal risk factors for childhood leukaemia
18. Height and lymphoblastic leukaemia
19. Big babies and infant leukemia: A role for insulin-like growth factor-I?
20. The risk profile of childhood leukaemia in Greece: A nationwide case-control study
21. Normal and aberrant growth
22. Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type
23. The leukemias
24. Age and sex distributions of hematological malignancies in the UK
25. Why is acute leukemia more common in males? A possible sex-determined risk linked to the ABO blood group genes
26. Birth characteristics and leukemia in childhood
27. Descriptive and analytical epidemiology of childhood malignancy in Japan
28. Birth weight and the incidence of childhood cancer
29. Cancers in children
30. Studies of insulin-like growth factors-I and -II by specific radioligand assays in umbilical cord blood
31. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects with intrauterine growth retardation
32. Interrelation between umbilical cord serum sex hormones, sex hormone-binding globulin, insulin-like growth factor 1, and insulin in neonates from normal pregnancies and pregnancies complicated by diabetes
33. Human growth hormone and IGF-I enhances the proliferation of leukemic blasts
34. Insulin-like growth factors stimulate erythropoiesis in serum-substituted umbilical cord blood cultures